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ABSTRACT A mechanistic understanding of how new phenotypes develop to over-
come the loss of a gene product provides valuable insight on both the metabolic
and regulatory functions of the lost gene. The pgi gene, whose product catalyzes
the second step in glycolysis, was deleted in a growth-optimized Escherichia coli
K-12 MG1655 strain. The initial knockout (KO) strain exhibited an 80% drop in
growth rate that was largely recovered in eight replicate, but phenotypically distinct,
cultures after undergoing adaptive laboratory evolution (ALE). Multi-omic data sets
showed that the loss of pgi substantially shifted pathway usage, leading to a redox
and sugar phosphate stress response. These stress responses were overcome by
unique combinations of innovative mutations selected for by ALE. Thus, the coordi-
nated mechanisms from genome to metabolome that lead to multiple optimal phe-
notypes after the loss of a major gene product were revealed.
IMPORTANCE A mechanistic understanding of how microbes are able to overcome
the loss of a gene through regulatory and metabolic changes is not well under-
stood. Eight independent adaptive laboratory evolution (ALE) experiments with pgi
knockout strains resulted in eight phenotypically distinct endpoints that were able
to overcome the gene loss. Utilizing multi-omics analysis, the coordinated mecha-
nisms from genome to metabolome that lead to multiple optimal phenotypes after
the loss of a major gene product were revealed.
KEYWORDS Escherichia coli, adaptive laboratory evolution, multi-omics analysis,
mutation analysis, pgi gene knockout, systems biology
The ﬂux split between upper glycolysis and the oxidative pentose phosphatepathway (oxPPP) at the glucose 6-phosphate (G6P) node is a major determinant of
the ﬂux state of a cell’s core metabolic function. This is particularly true when a cell is
exposed to glucose, which is commonly used is many laboratory medium formulations
and is found under many environmental conditions in nature. The loss of phosphog-
lucose isomerase (PGI), encoded by pgi, induces detrimental physiological conse-
quences (1–5). The removal of pgi generates an imbalance in glycolytic intermediates
from the loss of upper glycolytic ﬂux that leads to a loss of ﬁtness and induces a sugar
phosphate stress response. The sugar phosphate stress response involves the actions of
both small RNAs (sRNAs) and transcription factors (TFs) that induce transcription-level
changes aimed at alleviating the imbalance (6–8). The removal of pgi also generates an
overabundance of NADPH and redox imbalance by redirecting glycolytic ﬂux into the
oxPPP. NADPH provides reducing equivalents for biosynthesis. In addition, NADPH
plays an important role in reactive oxygen species (ROS) detoxiﬁcation by regenerating
reduced glutathione (gthrd) (9). Increased availability of NADPH in pgi knockout
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backgrounds has proven useful in various biotechnology applications in order to
increase cofactor and heterologous pathway production (1, 2, 10).
Adaptive laboratory evolution (ALE) of pgi mutants has been carried out to better
understand the physiological changes required to overcome genetic perturbation (3, 4).
ALE is an experimental method that introduces selection pressure (e.g., growth rate
selection) in a controlled environmental setting (11–13). Using ALE, organisms can be
perturbed from their evolutionary optimized homeostatic states, and their readjust-
ments can be studied during the course of adaptation to reveal novel and nonintuitive
component functions and interactions (14). Previous ALEs of pgi mutants have dem-
onstrated a rewiring of central metabolic ﬂuxes (4) and diversity in endpoint physio-
logical phenotypes (3). The diversity in endpoint physiological phenotypes is directly
attributed to the existence of alternate optimal metabolic and regulatory network
states that can achieve the same physiological function (3). However, the mechanisms
and coordination of the regulatory and metabolic network required to produce phys-
iologically distinct, yet ﬁt, phenotypes are not well understood. In addition, these
studies were conducted with a starting strain that was not previously optimized to the
growth conditions of the experiment. This confounds the interpretation of the exper-
imental results, because adaptations to the growth conditions and loss of the gene
occur simultaneously.
The consequence of the loss of a major metabolic gene can be studied at the
systems level through the integration of multi-omics data sets (i.e., metabolomics,
ﬂuxomics, proteomics, and transcriptomics) to gain deeper insight into the function of
the gene in the context of the biological system as a whole. Previous work has found
that the metabolic network is robust to perturbations through adjustments made at the
regulatory level that coordinate rerouting of ﬂux with enzyme level (5, 15). While these
studies reveal insights into the immediate response of gene loss, the adaptive changes
required to overcome the loss were not explored. In addition, improvements in omics
data acquisition and analysis methods could improve and reveal new relationships
between changes in omics data at one layer of the system to another.
In this study, a combination of experimental design (i.e., starting with a strain that
was preevolved on glucose M9 minimal medium) and systems analysis from multi-
omics data was used to mechanistically investigate how multiple phenotypes can
overcome the loss of pgi. First, the reduction in ﬁtness after the pgi KO was found to be
attributed to malfunctions in the regulatory and metabolic network that were incapa-
ble of handling the redox and glycolytic intermediate metabolite imbalance induced
from major shifts in central metabolic ﬂux. Second, all evolved pgi KO lineages regained
a substantial portion of ﬁtness but were found have mostly unique genotypes and
displayed unique physiologies. Third, the recovery in ﬁtness was enabled by mutations
that were selected for by ALE that altered the transcription regulatory network (TRN)
and metabolic ﬂuxes to alleviate the redox and sugar phosphate imbalance. These
regulatory and metabolic alterations were unique across all endpoints, which led to the
emergence of multiple optimal phenotypes.
RESULTS
Diversity in ALE endpoint phenotypes points to multiple optimal selection
outcomes. To eliminate the confounding variable of adaptation to the growth condi-
tions of the experiment, a wild-type E. coli K-12 MG1655 strain previously evolved under
glucose minimal medium at 37°C (16) (denoted “Ref”) was selected as the starting strain
(Fig. 1A). This selection was made to separate changes caused by adaptation to the loss
of a gene product from those caused by adaptation to the growth conditions of the
experiment.
PGI (encoded by pgi, phosphoglucose isomerase) was removed from the Ref strain
to generate strain uPgi (for “unevolved pgi knockout strain”) (Fig. 1B). The loss of pgi
resulted in an 81% loss in growth rate (Fig. 1C and D). Eight uPgi independently
inoculated starting cultures were simultaneously evolved on glucose minimal medium
at 37°C in an automated ALE platform (16, 17) denoted “evolved pgi knockout strains”
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(ePgi) (Fig. 1C). A statistically signiﬁcant increase in ﬁnal growth rate (Student’s t test,
P  0.05) was found in all ALE endpoints of the ePgi lineages (average  standard
deviation [SD], 284%  20% increase in growth rate) compared to the uPgi strain (Fig.
1D). Metabolomics, ﬂuxomics, transcriptomics, genomics, and phenomics data were
collected from exponentially growing cultures inoculated in triplicate from the Ref
strain, the uPgi strain, and each of the 8 independently evolved endpoint lineage
populations (ePgi01 to ePgi08). It is important to note that the data presented below
were derived from endpoint populations as opposed to isolated clones.
Statistically signiﬁcant variabilities in growth rate, acetate secretion, and glucose
uptake rate were found in the ePgi samples (Fig. 1D; see also Table S1 in the
supplemental material). Speciﬁcally, replicates 3, 4, 7, and 8 excreted acetate. Replicate
4, in particular, had acetate secretion levels similar to those of the uPgi strain and the
highest growth and glucose consumption rates of all endpoints. The overall mutation
load also differed across lineages. The overall numbers of mutations (mutation fre-
quency, 0.2) for each of the endpoint replicates were 15, 12, 9, 13, 7, 14, 9, and 7,
respectively (Table S7).
The different phenotypes and genotypes displayed by the endpoints raised two
deﬁning questions: what metabolic and regulatory changes occurred to allow for a
large improvement in ﬁtness without the use of upper glycolysis? And how were a
diversity of endpoint physiologies capable of overcoming the loss of PGI? To answer
these questions, intracellular metabolite levels, gene expression levels, and ﬂux levels
were measured for the Ref strain, uPgi strain, and ePgi endpoint populations (Tables S1
to S7).
PGI KO shifted metabolic ﬂux. Genome-scale metabolic ﬂux analysis (MFA) (18)
found signiﬁcant shifts in ﬂux splits throughout central metabolism in response to the loss
of PGI (Fig. 2 and Table S5). Note that all ﬂuxes discussed in the text passed observability
criteria described previously (18). Flux splits included the distribution of ﬂux through the
oxidative pentose phosphate pathway (oxPPP) (phosphogluconate dehydratase [EDD],
6-phosphogluconate dehydrogenase [GND], and 6-phosphogluconolactonase [PGL]), ﬂux
through the nonoxidative branch (nonOxPPP), ﬂux around the anaplaerotic reactions
D
ac
glc-D
0
2
ra
te
 (m
m
ol
*g
D
C
W
-1
*h
r-
1)
-10
-8
-6
-4
-2
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
gr
ow
th
 ra
te
 (h
r-
1)
KO EP
B
C
0.6
0.2
0.4
0.8
pgi01
pgi02
pgi03
pgi04
pgi05
pgi06
pgi07
pgi08
0 5 10 15 20 25 30 35 40
Time (days)
G
ro
w
th
 ra
te
(h
r-
1)
ref
PPP
G
ly
co
ly
si
s
TCA cycle
PGI,
pgi
Wild-type ALE KO ALE
KO ALE physiological characterization
Network reaction loss
A
0.7
1.0
uPgi
glc-D
g6p
pyr
ac
akg
succ
ru5p-D
g3p
pep
FIG 1 Evolution of knockout (KO) strains from a preevolved (i.e., optimized) wild-type strain. (A) Wild-type
(wt) E. coli (MG1655 K-12) was previously evolved on glucose minimal medium at 37°C (16). An isolate
from the endpoint of the evolutionary experiment was selected as the starting strain for subsequent KO
of pgi and adaptive laboratory evolution (ALE). (B) Adaptive laboratory evolution trajectories of the
evolved knockout lineages. Omics data were collected from the fresh KO, and endpoint lineages included
metabolomics, ﬂuxomics, physiology, DNA resequencing, and transcriptomics. (C) Phosphoglucose
isomerase (PGI) was disabled by the gene KO. PGI is the ﬁrst step in glycolysis and converts glucose
6-phosphate (G6P) to fructose 6-phosphate (F6P). (D) Growth rate and glucose (glc-D) uptake and acetate
(ac) excretion rates for unevolved KO (uPgi) and evolved KOs (ePgi). Error bars denote 95% conﬁdence
intervals from biological triplicates. succ, succinate.
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(phosphoenolpyruvate carboxylase [PPC], phosphoenolpyruvate carboxylase kinase
[PPCK], malate dehydrogenase [MALS], NADP-dependent malic enzyme 1 [ME1], and
ME2), ﬂux into the tricarboxylic acid (TCA) cycle or toward acetate secretion (citrate
synthase [CS], acetate secretion [ACt2rpp], and pyruvate dehydrogenase [PDH]), and
ﬂux through the lower glyoxylate shunt or through the lower TCA cycle (aconitase
[ACONTb], isocitrate dehydrogenase [ICDHyr], and isocitrate lyase [ICL]). A massive in-
crease of over 10,000-fold in ﬂux per mole glucose through the Entner-Doudoroff (ED)
pathway (EDD) was found (note that the Ref strain had only minimal ﬂux through the EDD),
while a minor 15.6% drop in ﬂux per mole glucose through GND was found in the uPgi
strain compared to that with the Ref strain. Redistribution of ﬂux through the nonOxPPP
was found. A 79% increase in ﬂux per mole glucose into the TCA through CS was offset by
an 87% drop in ﬂux per mole glucose into the TCA through PPC. A minor 6% drop in
acetate secretion per mole glucose was found. Further, a signiﬁcant 380.8% increase in ﬂux
per mole glucose through the glyoxylate shunt was found. These changes in major
metabolic pathways and ﬂux splits in the cell quantify the magnitude of the perturbation
and the initial response of the cell to losing the pgi gene function.
Perturbed glycolytic intermediates generated a sugar phosphate stress
response. Shifts in central metabolic ﬂuxes imbalanced central metabolic interme-
diate metabolite levels, leading to a sugar phosphate stress response. Liquid
chromatography-tandem mass spectrometry (LC-MS/MS) was used to quantify the
absolute metabolite concentrations of glycolytic intermediates, pentose phosphate
pathway (PPP), and TCA cycle intermediates (Table S2), and transcriptomics was
used to quantify the relative shifts in genes targeted by transcription factors (Tables
S2 to S4). All measured glycolytic and PPP intermediates changed signiﬁcantly in
the uPgi strain compared to the Ref strain (Fig. 3 and Table S2). In particular, an
approximate 5-fold increase in glucose 6-phosphate (G6P) was found in the uPgi strain
FIG 2 Changes in ﬂux splits pre- and postadaptive evolution. (A) Network diagram with reactions involved in ﬂux
splits annotated. Reactions included phosphogluconate dehydratase (EDD), 6-phosphogluconate dehydrogenase
(GND), 6-phosphogluconolactonase (PGL), phosphoenolpyruvate carboxylase (PPC), phosphoenolpyruvate carbox-
ylase kinase (PPCK), malate dehydrogenase (MALS), NADP-dependent malic enzyme 1 (ME1), NAD-dependent malic
enzyme (ME2), citrate synthase (CS), acetate secretion (ACt2rpp), pyruvate dehydrogenase (PDH), conversion of
cis-aconitate to isocitrate (icit) carried out by the second step of the aconitase enzyme (ACONTb), isocitrate
dehydrogenase (ICDHyr), and isocitrate lyase (ICL). PFK3, phosphofructokinase 3; TKT1, transketolase 1. (B)
Measured absolute ﬂuxes for the Ref strain, uPgi, and ePgi strains. Values are derived from averages taken from
triplicate cultures that were analyzed in duplicate (n  6).
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compared to the Ref strain (Fig. 4). G6P is the sole substrate of the pgi gene. Abnormal
elevations in G6P and an imbalance of the glycolytic intermediates in the uPgi strain
were found to induce the sugar phosphate toxicity response transcription factor (TF)
SgrR (6–8), as measured through the transcriptomic measurements. SgrR is thought to
bind hexose phosphates and induce the expression of the small RNA sgrS (6–8) (Fig. 4D
and E). ePgi strains dampened sgrS expression, which was highly overexpressed in the
uPgi strain. Further, sgrS transcriptionally regulates a number of genes, including the
pur regulon, ptsG, and genes involved in bioﬁlm formation and curli formation (7, 8,
19–21).
Imbalances in central carbon intermediates induced TRN responses that were
consistent with the literature. Many E. coli TFs are activated by metabolites (22–26).
Thus, changes in metabolite levels were investigated to reveal potential TRN responses
as measured by changes in expression proﬁles associated with well-known TF regulons.
Many of the measured expression changes appeared to conﬂict with optimal ﬁtness.
Speciﬁcally, the glp regulon required for glycerol import and catabolism was upregu-
lated by C-reactive protein (CRP)-cAMP (27). cAMP was signiﬁcantly elevated in the uPGI
strain (supplemental material). This hard-wired regulation led to massive upregulation
of the glp regulon in the uPgi strain, which could potentially have led to counterpro-
ductive allocation of the proteome to glycerol metabolism.
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FIG 3 An imbalance in redox carriers. (A) Box-and-whisker plots of log-normalized absolute metabolite levels (mol · gram dry cell weight [gDCW]1 norm) of
the redox carriers NAD(P)(H) and the reduced (gthrd) and oxidized (gthox) glutathione. Network diagram of the interconversion of nadh to nad, nadp to nadph,
and gthox and nadph to gthrd and nadp. An imbalance in glycolytic and PPP intermediates and their downstream biosynthetic components are shown. (B)
Schematic of the connection between the PPP precursor ribose 5-phosphate (r5p) and downstream amino acid and nucleotides L-histidine (his-L), IMP, and UMP.
Box-and-whisker plots of absolute metabolite levels of r5p, his-L, imp, and ump. (C) Schematic of the connection between the glycolytic precursor phosphoenol
pyruvate (PEP) and downstream aromatic amino acids L-tryptophan (trp-L), L-tyrosine (tyr-L), and L-phenylalanine (phe-L). Box-and-whisker plots of PEP, trp-L,
tyr-L, and phe-L. Values are derived from averages taken from triplicate cultures that were analyzed in duplicate (n  6).
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Interestingly, the hexose phosphate importer gene, uhpT, was overexpressed in the
uPgi strain compared to the Ref strain. High periplasmic G6P plausibly activated the
uhpAB two-component system, which in turn upregulates the expression of the hexose
phosphate importer gene uhpT (28–30). This result suggests that the concentration
build-up in the uPgi strain was so great that G6P spilled over into the periplasmic space
(31, 32) (Fig. 3, top). Increased expression of uhpT could have generated a loop whereby
excessive G6P that spilled into the periplasmic space would be reimported into the
cytosol. The transcriptional attenuation of ptsG by sgrS may act to compensate for this
futile cycle.
It should be noted that in the present context, the two examples given above (i.e.,
the glp regulon and G6P cycling) could be considered counterproductive and not
aligning with optimal growth. However, in a different environment, these hard-wired
regulatory circuits could play a critical role in maintaining optimal physiology. This
provides evidence that the combination of tightly controlled laboratory setting, gene
knockout, and multi-omics data collection and analysis described here provided a
useful means to reveal these hard-wired responses.
Imbalances in central carbon intermediates were mirrored in amino acid pools.
In addition to regulatory shifts, biomass components directly reﬂected the levels of
their biosynthetic precursors (Fig. 3B and C). The aromatic amino acids L-tyrosine (tyr-L),
L-phenylalanine (phe-L), and L-tryptophan (trp-L) are derived from phosphoenolpyru-
vate (PEP). A decrease in PEP levels in the uPgi strain and a rise in PEP levels in the ePgi
strains were mirrored by all three of the amino acids (Fig. 3C). An increase in ribose
5-phosphate (r5p) levels in the uPgi and ePgi strains were mirrored by the downstream
amino acid L-histidine (his-L) and nucleotide UMP (Fig. 3B).
Similar trends were found for amino acid and precursor pairs L-serine (ser-L) and
2-phosphogluconate (2pg), L-aspartate (asp-L) and oxaloacetate (oaa), L-alanine (ala-L)
and pyruvate (pyr), and L-glutamate (glu-L), L-glutamine (glu-L), and alpha-ketoglutarate
(akg), respectively (Table S2). Perturbations in the distribution and abundance of
proteogenic amino acids have been shown to alter protein synthesis rates, leading to
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FIG 4 KO of PGI led to a hexose phosphate toxicity response. The magnitude of G6P in the initial knockout led to a deleterious cycle
whereby leakage of hexose phosphate across the inner membrane (31, 32) induced hexose phosphate reuptake via the uhpBC
two-component system and uhpT hexose phosphate transporter gene (28–30). (A) A network map and regulatory schematic of the
reactions into and out of the G6P node. The reaction in red is removed through the PGI KO. (B) A mechanistic schematic of the uhpBC
two-component system that sensed periplasmic hexose phosphate. The transcription factor UphA positively upregulated the expression
of the hexose phosphate importer gene uhpT. (C) Metabolite, expression, and ﬂux levels near the node of perturbation. Abnormal
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a drop in the growth rate (33–37). The drop in the growth rate of the uPgi strain and
regain of ﬁtness in the ePgi strains provide evidence that an imbalance in glycolytic
intermediates directly alters growth rate via manipulating proteogenic amino acid
levels.
The regulatory response to elevated G6P levels and the relationship between
biomass components and their precursors reﬂected the importance of balancing
glycolytic, PPP, and TCA cycle intermediates to maintain balanced ratios of amino acid
levels for protein biosynthesis and purine/pyrimidine mononucleotides for nucleotide
biosynthesis.
Mutations that targeted alternative glucose import systems corrected TRN
responses and helped rebalance glycolytic intermediate levels. Major alterations in
expression proﬁles were found in the evolved KO strains that correlated well with
mutations detected in TFs. These included mutations to galR (Fig. 5) and malT (Fig. 6)
in the ePgi strains. A 22-nucleotide deletion in the small-molecule-binding domain of
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and the H-T-H DNA-binding region is highlighted in magenta. Images created using the VMD software tool
(v. 1.9.2; http://www.ks.uiuc.edu/Research/vmd/). (C) Mutation frequency for galR, metabolite concentra-
tion for cAMP, and expression proﬁles of galR-controlled operons. Note the increased expression of galP
and galETKM in ePgi07. Metabolite concentrations are derived from averages taken from triplicate cultures
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galR in ePgi07 appears to negate the repression of the galR-controlled operons (Fig. 5).
These include galETKM, galP, and mglBAC that encode enzymes for galactose catabo-
lism, symport, and ABC transport, respectively (38). These operons are also regulated by
CRP-cAMP and were not expressed in the Ref strain. The galactose importers have lesser
afﬁnity for the transport of glucose, which may give ePgi07 an additional route to
import and catabolize glucose from the environment. In addition, the mutation may
have aided in conserving PEP for aromatic amino acid production, which was limiting
ﬁtness in all of the pgi strains (as discussed previously).
In another example, a mobile element insertion (MOB) that truncated the MalT TF in
ePgi06 was found that appeared to silence the expression of operons controlled by
MalT (39) (Fig. 6). The MOB introduced a stop codon that truncated the MalT peptide
from 901 amino acids to 29 amino acids. All binding domains and catalytic sites were
cleaved (40, 41). MalT-controlled genes are involved in glycogen turnover and may give
ePgi06 an advantage in controlling the levels of hexose phosphates that are converted
to and broken down from glycogen.
An imbalance in redox carriers was compensated for by shifts in hydrogenase
ﬂux and buffered by glutathione. Genome-scale MFA (18) conﬁrmed that removal of
the pgi gene diverted all upper glycolytic ﬂux into the oxidative pentose phosphate
pathway (oxPPP) (Fig. 2). The loss of PGI resulted in a 556.7% increase in ﬂux per mole
glucose toward the oxPPP in the uPgi strain (14.4 and 94.7% ﬂux per mole glucose in
the Ref and uPgi strains, respectively). Note that as discussed previously, a large portion
of the ﬂux into the oxPPP was diverted down the ED pathway after the ﬁrst NADPH-
generating step to avoid generating additional NADPH via the second NADPH-
generating step of the oxPPP (Fig. 2). Rearrangement of ﬂux through hydrogenases to
compensate for the increased ﬂux toward NADPH generation were found (Fig. 2).
Notable is the reversed utilization of the transhydrogenases from net NADPH to NADH
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generation in the uPgi and ePgi strains (approximately 8-fold change in the uPgi and
ePgi strains in NADPH generation through pyridine nucleotide transhydrogenase
[THD2pp], and 3-fold change in the uPgi strain and 1 to 4-fold change in ePgi
strains in NADH generation through pyridine nucleotide transhydrogenase [NA-
DTRHD]). Other hydrogenases signiﬁcantly altered include serine dehydrogenase
(LSERDHr, note the altered levels of ser-L mentioned previously), as well as isocitrate
dehydrogenase (ICD) and glutamate synthase (GLUSy, note the altered levels of akg,
gln-L, and glu-L mentioned previously).
The increased ﬂux through the oxPPP would generate an increased abundance of
NADPH and thus a redox imbalance. LC-MS/MS (42) was used to quantify the absolute
metabolite concentrations of the redox carriers. While major shifts in the redox carriers
were found (Fig. 3A), a statistically signiﬁcant change in NADPH between the Ref and
uPgi strains was not found. However, statistically signiﬁcant changes in NADP and
reduced and oxidized glutathione were found. This indicates a potential rapid buffering
of NADPH by the glutathione via glutathione reductase (GTHOr) (Fig. 3A).
High NADPH promoted activation of oxidative stress responders. Mutations in
soxR in ePgi02 and rseC in ePgi01 were found that altered the expression of oxidative
stress genes (Fig. 7). The soxR mutation truncated the Fe-S cluster binding site of the
SoxR peptide by introducing a premature stop codon (Fig. 7C). Cleavage of the Fe-S
cluster does not affect DNA binding, but transcriptional activation of the target genes
soxS and fumC and transcriptional deactivation of soxR are impaired (43–45). soxR was
upregulated in ePgi02, which indicated that the mutation negated the self-regulation
of soxR.
The rseC single-nucleotide deletion introduced a frameshift that truncated a large
portion of the transmembrane helix region starting several amino acids from the initial
deletion (Fig. 7D) that may affect Rsx-RseC complex formation or activity. rseC mutants
were found previously to exhibit constitutive soxS expression by preventing the
Rsx-RseC complex from inhibiting reduction and inactivating SoxR (46) (Fig. 7A). soxS,
as well as many of its downstream activation targets, including acrA, acrB, ﬂdA, fpr, inaA,
and sodA, were upregulated in ePgi01, which indicated that the mutation promotes the
expression of soxS. The Rsx-RseC complex prevents the reduction and inactivation of
SoxR (46).
Mutations in transhydrogenases helped alleviate redox imbalance. Mutations
selected during adaptive evolution also introduced innovations that targeted metabolic
network elements involved in NADPH production. Mutated transhydrogenases in-
cluded sthA, pntB, icd, and zwf. The soluble and membrane-bound transhydrogenases
act to interconvert NADP(H) and NAD(H) (47, 48) (Fig. 8). Mutations in the soluble sthA
(50) and membrane-bound pntB (51) transhydrogenase genes in ePgi07 and ePgi04,
respectively, were found (Fig. 8). The sthA mutation appeared near the dimerization
domain and may affect enzyme complex formation. The pntBmutation appeared in the
transmembrane region and may affect catalytic activity or membrane association. It has
been demonstrated that altered activities of sthA and pntAB confer a ﬁtness advantage
in pgi mutant strains by rebalancing the ratio of NADH to NADPH (47, 48). Interestingly,
mutations in sthA and pntB were selected for in previous evolutions of a pgi strain (3).
This observation provides further evidence that the sthA and pntB mutations provided
a ﬁtness advantage to ePgi07 and ePgi04 by rebalancing the ratios of NADH to NADPH
via modulating the activities of the transhydrogenases. Note that ePgi07 and ePgi04
were also found to have the highest increases in ﬂux through the soluble transhydro-
genases.
Isocitrate dehydrogenase (ICD) catalyzes the conversion of isocitrate (icit) to
2-oxoglutarate (akg) while reducing NADP to NADPH (Fig. 9). The activity of ICD also
regulates the ﬂux split between the full TCA cycle and the glyoxylate shunt (49–51). A
point mutation at residue 395 that changed the amino acid from positively charged
(L-arginine) to negatively charged (L-cysteine) in ICD was found in all ePgi replicates
except replicate 7 (Fig. 9). The mutation occurs 4 Å from the phosphate moiety of
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NADP. Residue 395 has been shown to be directly involved in NADP binding (52) and
appears to allow the mutated enzyme to either utilize NAD as a cofactor or exclude
NADPH from the active site by like-charge repulsion. The mutation was found to
redirect ﬂux through the glyoxylate shunt instead of the TCA cycle and may provide a
ﬁtness advantage to the ePgi strains by limiting the production of NADPH in the TCA
cycle.
The metabolome, ﬂuxome, transcriptome, and genome were unique in each
ePgi strain.While the ePgi strains were not able to recover the ﬁtness of the Ref strain,
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FIG 7 Mutations in soxR and rseC that altered the expression of oxidative stress genes. (A) Protein-protein interaction
schema between SoxR and Rsx-RseC. In the reduced form, the iron sulfur clusters of the SoxR homodimers sense the
presence of free radicals and ROS (79, 80). The oxidation of the iron sulfur clusters by free radicals and ROS induces a
conformation changes from the inactive form to the active form (81). While both reduced and inactive forms and oxidized
and active forms of SoxR are capable of binding DNA, only the active form is capable of activating or inhibiting
transcription (43, 82–85). The Rsx-RseC complex prevents reduction and inactivation of SoxR (46). (B) Regulatory schematic
of a subset of SoxR and SoxS-controlled operons. (C) Crystal structure of SoxR (86). The soxR single-nucleotide polymor-
phism (SNP) eliminated the Fe-S cluster binding site of the SoxR peptide. The SoxR DNA-binding region in proximity to
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are shown in red. AAs, amino acids. Images in panels C and D were created using the VMD software tool (v. 1.9.2;
http://www.ks.uiuc.edu/Research/vmd/). (E) Mutation frequency and gene expression proﬁles. Gene expression values are
derived from averages of biological duplicates.
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they were able to recover the initial growth rate of wild-type MG1655. Many interme-
diate and cofactor levels, including G6P, remained perturbed in ePgi strains to various
degrees. However, the majority of initially elevated transcription involving sugar phos-
phate stress, carbon catabolite repression, the uhpT transporter, and other general
stress responders in the uPgi strain were dampened or completely shut down in ePgi
strains. This indicated that the TRN had evolved to cope with the changed metabolome.
Many of these changes to the TRN could be directly attributed to mutations.
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FIG 8 Mutations in the soluble sthA (50) and membrane-bound pntB (51) transhydrogenases that potentially aid in
balancing NAD(P)(H) cofactors. (A) Schematic of the sthA and pntAB operons. (B) Network diagrams of the soluble pyridine
nucleotide transhydrogenase (NADTRHD) reaction catalyzed by sthA and the membrane-bound pyridine nucleotide
transhydrogenase (THD2pp) reaction catalyzed by pntAB. (C) Mutation frequency and metabolite and expression levels
near the genes. (D) The sthA mutation in ePgi04 appeared near the dimerization domain and may affect enzyme complex
formation. (E) The pntB mutation in ePgi07 appeared in the transmembrane region and may affect catalytic activity or
membrane association. It has been demonstrated that the altered activities of sthA and pntAB confer a ﬁtness advantage
in pgi mutant strains by rebalancing the ratios of NADH to NADPH (47, 48). Metabolite concentrations are derived from
averages taken from triplicate cultures that were analyzed in duplicate (n  6). Gene expression values are derived from
averages of biological duplicates. Images in panels D and E were created using the VMD software tool (v. 1.9.2;
http://www.ks.uiuc.edu/Research/vmd/).
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The recovery to wild-type levels was in part made possible by a complete rewiring
of central carbohydrate metabolic ﬂux splits (Fig. 3). The rewiring differed substantially
between ePgi strains. While an increase in ﬂux through GND and a decrease in ﬂux
through the ED pathway occurred in all ePgi endpoints, the ﬂux through each pathway
differed substantially. GND ﬂux increases varied from 389.9 to 604.6% per mole glucose
compared to the Ref strain, and ED pathway ﬂux increases varied from 150.9 to
4,463.8% per mole glucose compared to the Ref strain. nonOxPPP ﬂux varied substan-
tially among the strains, even altering between net forward and reverse utilization of
transaldolase A (TALA). Of particular note, ﬂux through PPC was regained in ePgi04 and
ePgi07, and ﬂux through the glyoxylate shunt was lost in ePgi07. The increased ﬂux
through the PPC and loss of ﬂux through the glyoxylate shunt in particular correlate
with mutations in the transhydrogenases and icd, respectively.
Conclusion. The loss of pgi induced massive perturbations to the metabolome,
ﬂuxome, and transcriptome in E. coli and led to a greatly retarded postknockout growth
rate. In contrast to previous work (5), it was found that the loss of pgi induced major
changes in all omics data measured not just local to the perturbation but also in distal
network locations. Flux rerouting to compensate for the loss of pgi imbalanced the PPP
and glycolytic intermediate levels, which led to a sugar phosphate stress response. The
deleterious effects of this response were attributed to a misallocation of protein, a
deleterious cycle of reimport of hexose phosphate, and alterations in the distributions
and amount of proteogenic amino acids and nucleotides. Redistribution of glycolytic
ﬂux into the oxPPP generated an overabundance of NADPH, which led to a redox
imbalance.
ALE selected for mutations that helped alleviate redox and glycolytic intermediate
imbalances. Differences in the metabolome and mutation landscape led to a diversity
of expression and ﬂuxome proﬁles in ePgi strains. The multitude of hydrogenases and
routes to generate glycolytic intermediates allowed for regulatory and metabolic
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triplicate cultures that were analyzed in duplicate (n  6). Gene expression values are derived from averages of biological duplicates.
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ﬂexibility in overcoming redox and glycolytic intermediate imbalance. Finally, the
diversity in ﬁxed mutations and the concomitant emergence of multiple optimal
phenotypes was a manifestation of this metabolic ﬂexibility. Additional studies utilizing
ALE to uncover the response of a cell to a major network perturbation are likely to
uncover additional mechanisms available to biological networks to overcome such
major perturbations.
MATERIALS AND METHODS
Biological material, analytical reagents, and experimental conditions. (i) Biological material. A
wild-type E. coli K-12 MG1655 strain previously evolved under glucose minimal medium at 37°C (ATCC
700926) (16, 17) served as the starting strain. Lambda Red-mediated DNA mutagenesis (53) was used to
create the knockout strains (DNA mutagenesis and PCR conﬁrmation primers are given in Table 1,).
Knockouts were conﬁrmed by PCR and DNA resequencing. The pgi gene encoding triphosphate
isomerase (TPI) was removed. All cultures were grown in 25 ml of unlabeled or labeled glucose M9
minimal medium (54) with trace elements (55) and sampled from a heat block in 50-ml autoclaved tubes
that were maintained at 37°C and aerated using magnetics.
(ii) Materials and reagents. Uniformly labeled [13C]glucose and 1-[13C]glucose was purchased from
Cambridge Isotope Laboratories, Inc. (Tewksbury, MA). Unlabeled glucose and other medium compo-
nents were purchased from Sigma-Aldrich (St. Louis, MO). LC-MS reagents were purchased from
Honeywell Burdick & Jackson (Muskegon, MI), Fisher Scientiﬁc (Pittsburgh, PA), and Sigma-Aldrich.
(iii) Reaction knockout selection. iJO1366 (56) was used as the metabolic model for E. coli
metabolism; GLPK (version 4.57) was used as the linear program solver. Markov chain Monte Carlo
(MCMC) sampling (57) was used to predict the ﬂux distribution of the optimized reference strain. Uptake,
secretion, and growth rates were constrained to the measured average value the SD. Potential reaction
deletions were ranked by (i) averaged sampled ﬂux, (ii) the number of immediate upstream and
downstream metabolites that could be measured, and (iii) the number of genes required to produce a
functional enzyme. The reactions involved in sampling loops that were spontaneous, computationally or
experimentally essential, or not actively expressed under the experimental growth conditions were not
included in the analysis. Also, reactions that would require more than one genetic alteration to abolish
activity were excluded. The top 9 reaction deletions from the rank-ordered set of reactions that met the
above-mentioned criteria were chosen for implementation.
Adaptive laboratory evolution. Cultures were serially propagated (100 l passage volume) in 15-ml
(working volume) ﬂasks of M9 minimal medium with 4 g/liter glucose, kept at 37°C, and well mixed for
full aeration. An automated system passed the cultures to fresh ﬂasks once they had reached an optical
density at 600 nm (OD600) of 0.3 (equivalent to an OD600 of 1 on a traditional spectrophotometer with
a 1-cm path length; Tecan Sunrise plate reader), a point at which nutrients were still in excess and
exponential growth had not started to taper off (conﬁrmed with growth curves and high-performance
liquid chromatography [HPLC] measurements). Four OD600 measurements were taken from each ﬂask,
and the slope of ln(OD600) versus time determined the culture growth rates. A cubic interpolating spline
constrained to be monotonically increasing was ﬁt to these growth rates to obtain the ﬁtness trajectory
curves.
Multi-omics data processing. (i) Phenomics. Physiological measurements for culture density were
measured at 600 nm absorbance with a spectrophotometer and correlated to cell biomass. Samples to
determine substrate uptake and secretion were ﬁltered through a 0.22-m ﬁlter (polyvinylidene diﬂu-
oride [PVDF]; Millipore) and measured using refractive index (RI) detection by HPLC (Agilent 12600
Inﬁnity) with a Bio-Rad Aminex HPX87-H ion exclusion column (injection volume, 10 l) and 5 mM H2SO4
as the mobile phase (0.5 ml/min, 45°C). Growth, uptake, and secretion rates were calculated from a
minimum of four steady-state time points.
(ii) LC-MS/MS instrumentation and data processing. Metabolites were acquired and quantiﬁed on
Qtrap 5500 mass spectrometer (AB Sciex, Framingham, MA) and processed using MultiQuant 3.0.1, as
described previously (42). Mass isotopomer distributions (MIDs) were acquired on the same instrument
and processed using MultiQuant 3.0.1 and PeakView 2.2, as described previously (58).
(iii) Metabolomics. Internal standards were generated as described previously (59). All samples and
calibrators were spiked with the same amount of internal standard taken from the same batch of internal
standards. Calibration curves were run before and after all biological and analytical replicates. The
consistency of quantiﬁcation between calibration curves was checked by running a quality control
sample that was composed of all biological replicates twice a day. Solvent blanks were injected every
TABLE 1 Primers used to generate the pgi KO strains in this study
Primer Name Sequence
Conﬁrmation
Name Sequence
F_KO_primer pgi_F_KO_primer ACAATTCTCAAAATCAGAAGAGTATTGCTAATGAAAAACATCAAT
CCAACGCAGACCGCTATTCCGGGGATCCGTCGACC
F_conf_pr AGCGGGGCGGTTGTCAACGA
R_KO_primer pgi_R_KO_primer CGCCTTATCCGGCCTACATATCGACGATGATTAACCGCGCCA
CGCTTTATAGCGGTTAATGTGTAGGCTGGAGCTGCTTC
R_conf_pr TTTATCTGATAAAAAAATGC
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ninth sample to check for carryover. System suitability tests were injected daily to check instrument
performance.
Metabolomics samples were acquired from triplicate cultures (1 ml of cell broth at an OD600 of1.0) using
a previously described method (60). A pooled sample of the ﬁltered medium that was resampled using the
fast Swinnex ﬁltration (FSF) technique and processed in the same way as the biological triplicates was used
as an analytical blank. Extracts obtained from triplicate cultures and reﬁltered medium were analyzed in
duplicate. The intracellular values reported, unless otherwise noted, are derived from the average of the
biological triplicates (n 6). Metabolites in the pooled ﬁlteredmediumwith a concentration greater than 80%
of that found in the triplicate samples were not analyzed. In addition, metabolites that were found to have
a quantiﬁable variability (relative standard deviation [RSD], 50%) in the quality control samples or any
individual components with an RSD of 80 were not used for analysis.
Missing values were imputed using a bootstrapping approach, as coded in the R package Amelia II
(version 1.7.4, 1,000 imputations) (61). The remaining missing values were approximated as 1⁄2 the lower
limit of quantiﬁcation for the metabolite normalized to the biomass of the sample. Prior to statistical
analyses, metabolite concentrations were log normalized to generate an approximately normal distri-
bution using the R package LMGene (62) (version 3.3, “mult”  “TRUE,” “lowessnorm”  “FALSE”). A
Bonferroni-adjusted P value cutoff of 0.01, as calculated from Student’s t test, was used to determine
signiﬁcance between metabolite concentration levels. The glog-normalized values or the median-
normalized values to the reference strain (fold change [FC] of the median versus the Ref strain) were used
for downstream statistical analyses.
(iv) Fluxomics. Fluxomics samples were acquired from triplicate cultures (10 ml of cell broth at an
OD600 of 1.0) using a modiﬁed version of the FSF technique, as described previously (58). MIDs were
calculated from biological triplicates run in analytical duplicates (n  6). MIDs with an RSD greater than
50% were excluded. In addition, MIDs with a mass that was found to have a signal greater than 80% in
unlabeled or blank samples were excluded. A previously validated genome-scale MFA model of E. coli
with minimal alterations was used for all MFA estimations using INCA (version 1.4) (63), as described
previously (18). The model was constrained using MIDs, as well as measured growth, uptake, and
secretion rates. Best ﬂux values that were used to calculate the 95% conﬁdence intervals were estimated
from 500 restarts.
The 95% conﬁdence intervals were used as lower and upper bound reaction constraints for further
constraint-based analyses. MFA-derived constraints that violated optimality were discarded and resa-
mpled. The descriptive statistics (i.e., mean, median, interquartile ranges, minimum, maximum, etc.) for
each reaction for each model were calculated from 5,000 points sampled from 5,000 steps using
optGpSampler (version 1.1) (64), which resulted in an approximate mixed fraction of 0.5 for all models.
A permuted P value of 0.05 and geometric fold change of sampled ﬂux values of 0.001 were used to
determine differential ﬂux levels, differential metabolite utilization levels, and differential subsystem
utilization levels between models. Demand reactions and reactions corresponding to unassigned,
transport; outer membrane porin, transport; inner membrane, inorganic ion transport and metabolism,
transport; and outer membrane, nucleotide salvage pathway, oxidative phosphorylation were excluded
from differential ﬂux analysis. The geometric fold change of the mean between models and the reference
model was used for hierarchical clustering; the median, interquartile ranges, minimum, and maximum
values of each sampling distribution for each reaction and model were used as representative samples
for downstream statistical analyses.
(v) Transcriptomics. Total RNA was sampled from triplicate cultures (3 ml of cell broth at an OD600 of
1.0), immediately added to 2 volumes of Qiagen RNAprotect bacteria reagent (6 ml), vortexed for 5 s,
incubated at room temperature for 5 min, and immediately centrifuged for 10 min at 17,500 rpm. The
supernatant was decanted, and the cell pellet was stored at 80°C. Cell pellets were thawed and incubated
with Ready-Lyse lysozyme, SUPERaseIn, protease K, and 20% SDS for 20 min at 37°C. Total RNA was isolated
and puriﬁed using the Qiagen RNeasy minikit columns and following vendor procedures. An on-column
DNase treatment was performed for 30 min at room temperature. RNA was quantiﬁed using a NanoDrop
spectrophotometer and assessed for quality by running an RNA Nano chip on a Bioanalyzer. The rRNA was
removed using Epicentre’s Ribo-Zero rRNA removal kit for Gram-negative bacteria. A Stranded RNA sequenc-
ing (RNA-Seq) kit (catalog no. KK8401; Kapa Biosystems) was used, according to the manufacturer’s protocol,
to create sequencing libraries with an average insert length of around300 bp for two of the three biological
replicates. Libraries were run on a MiSeq and/or HiSeq platform (Illumina).
RNA-Seq reads were aligned using Bowtie (version 1.1.2, with default parameters) (65). Expression levels
for individual samples were quantiﬁed using Cufﬂinks (version 2.2.1, library type fr-ﬁrststrand) (66). The quality
of the reads was assessed by tracking the percentage of unmapped reads and expression level of genes that
mapped to the ribosomal gene loci rrsA to rrsF and rrlA to rrlF. All samples had a percentage of unmapped
reads of less than 7%. Differential expression levels for each condition (n  2 per condition) compared to
either the starting strain or initial knockout strain were calculated using Cuffdiff (version 2.2.1, library type
fr-ﬁrststrand, library norm geometric) (66). Genes with a 0.05 false-discovery rate (FDR)-adjusted P value of
0.01 were considered differentially expressed. The expression levels for individual samples for all combi-
nations of conditions tested in downstream statistical analyses were normalized using Cuffnorm (version 2.2.1,
library type fr-ﬁrststrand, library norm geometric) (66). Genes with unmapped reads were imputed using a
bootstrapping approach as coded in the R package Amelia II (version 1.7.4, 1,000 imputations). The remaining
missing values were ﬁlled using the minimum expression level of the data set. Normalized fragments per
kilobase per million (FPKM) values for gene expression were log2 normalized to generate an approximately
normal distribution prior to any statistical analysis. All replicates for a given condition were found to have a
pairwise Pearson correlation coefﬁcient of 0.95 or greater.
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(vi) DNA resequencing. Total DNA was sample from an overnight culture (1 ml of cell broth at an
OD600 of 2.0) and immediately centrifuged for 5 min at 8,000 rpm. The supernatant was decanted, and
the cell pellet was frozen at 80°C. Genomic DNA was isolated using a NucleoSpin tissue kit (catalog no.
740952.50; Macherey-Nagel), according to the manufacturer’s protocol, including treatment with RNase
A. Resequencing libraries were prepared using a Nextera XT kit (catalog no. FC-131-1024; Illumina),
following the manufacturer’s protocol. Libraries were run on a MiSeq platform (Illumina). DNA rese-
quencing reads were aligned to the E. coli reference genome (GenBank accession no. U00096.2) using
breseq (version 0.26.0) (67) as populations. Mutations with a frequency of less than 0.1, P value greater
than 0.01, or quality score less than 6.0 were removed from the analysis. In addition, genes corre-
sponding to crl, insertion elements (i.e., insH1, insB1, and insA), and the rhs and rsx gene loci were
not considered for analysis due to repetitive regions that appear to cause frequent miscalls when
using breseq. mRNA and peptide sequence changes were predicted using BioPython (https://github
.com/biopython/biopython.github.io/). Large regions of DNA (minimum of 200 consecutive indices)
where the coverage was two times greater than the average coverage of the sample were considered
duplications.
Structural analysis. Corresponding Protein Data Bank (PDB) ﬁles for genes with a mutation of
interest were downloaded from PDB (68, 69). Structural models for genes for which there were no
corresponding PDB ﬁles were taken from I-TASSER-generated homology models (70) or generated using
the I-TASSER protocol (71). The BioPython-predicted sequence changes and important protein features
as listed in EcoCyc (72) were visualized and annotated using VMD (73).
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